Avid Bioservices Inc (CDMO)

[r622102675]

The cto applies to this http://www.sec.gov/Archives/edgar/data/704562/000101968710001415/0001019687-10-001415-index.htm

10.17 Exclusive Patent License Agreement between The University of Texas System and Peregrine Pharmaceuticals, Inc. effective as of August 18, 2005 *
10.18 Amendment No. 1 to Exclusive Patent License Agreement between The University of Texas System and Peregrine Pharmaceuticals, Inc. dated June 1, 2009 *
10.19 Exclusive Patent License Agreement between The University of Texas System and Peregrine Pharmaceuticals, Inc. effective as of August 1, 2001 *
10.20 Amendment No. 1 to Exclusive Patent License agreement between The University of Texas System and Peregrine Pharmaceuticals, Inc. dated June 1, 2009 *
10.21 Non-Exclusive Cabilly Patent License Agreement between Genentech, Inc. and Peregrine Pharmaceuticals, Inc. effective as of November 5, 2003 *
10.22 Commercial License Agreement between Avanir Pharmaceuticals, Inc. and Peregrine Pharmaceuticals, Inc. dated December 1, 2003 *
10.23 License Agreement between Lonza Biologics PLC and Peregrine Pharmaceuticals, Inc. dated July 1, 1998 *
10.24 License Agreement between Lonza Biologics PLC and Peregrine Pharmaceuticals, Inc. dated March 1, 2005 *


..r